BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36362067)

  • 1. Genetic Aspects of Age-Related Macular Degeneration and Their Therapeutic Potential.
    Stradiotto E; Allegrini D; Fossati G; Raimondi R; Sorrentino T; Tripepi D; Barone G; Inforzato A; Romano MR
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine.
    Maugeri A; Barchitta M; Mazzone MG; Giuliano F; Agodi A
    Biomed Res Int; 2018; 2018():7532507. PubMed ID: 30225264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.
    Geerlings MJ; de Jong EK; den Hollander AI
    Mol Immunol; 2017 Apr; 84():65-76. PubMed ID: 27939104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence variants in PPARGC1A, a gene encoding a coactivator of the ω-3 LCPUFA sensing PPAR-RXR transcription complex, are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways.
    SanGiovanni JP; Chen J; Sapieha P; Aderman CM; Stahl A; Clemons TE; Chew EY; Smith LE
    PLoS One; 2013; 8(1):e53155. PubMed ID: 23335958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
    Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
    Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2/HTRA1 loci.
    Pappas CM; Zouache MA; Matthews S; Faust CD; Hageman JL; Williams BL; Richards BT; Hageman GS
    Hum Genomics; 2021 Sep; 15(1):60. PubMed ID: 34563268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related macular degeneration and the complement system.
    Khandhadia S; Cipriani V; Yates JR; Lotery AJ
    Immunobiology; 2012 Feb; 217(2):127-46. PubMed ID: 21868123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the complement system in age-related macular degeneration.
    Weber BH; Charbel Issa P; Pauly D; Herrmann P; Grassmann F; Holz FG
    Dtsch Arztebl Int; 2014 Feb; 111(8):133-8. PubMed ID: 24622760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in complement regulators and susceptibility to age-related macular degeneration.
    Cipriani V; Matharu BK; Khan JC; Shahid H; Stanton CM; Hayward C; Wright AF; Bunce C; Clayton DG; Moore AT; Yates JR
    Immunobiology; 2012 Feb; 217(2):158-61. PubMed ID: 22024702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement System and Potential Therapeutics in Age-Related Macular Degeneration.
    Park YG; Park YS; Kim IB
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic approach to stratification of risk for age-related macular degeneration.
    Zanke B; Hawken S; Carter R; Chow D
    Can J Ophthalmol; 2010 Feb; 45(1):22-7. PubMed ID: 20130705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.
    Anderson DH; Radeke MJ; Gallo NB; Chapin EA; Johnson PT; Curletti CR; Hancox LS; Hu J; Ebright JN; Malek G; Hauser MA; Rickman CB; Bok D; Hageman GS; Johnson LV
    Prog Retin Eye Res; 2010 Mar; 29(2):95-112. PubMed ID: 19961953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.
    Qin S; Dong N; Yang M; Wang J; Feng X; Wang Y
    J Immunol Res; 2021; 2021():9945725. PubMed ID: 34368372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of genetic variation in the complement system in age-related macular degeneration.
    de Jong S; Gagliardi G; Garanto A; de Breuk A; Lechanteur YTE; Katti S; van den Heuvel LP; Volokhina EB; den Hollander AI
    Prog Retin Eye Res; 2021 Sep; 84():100952. PubMed ID: 33610747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of CFD polymorphisms with advanced age-related macular degeneration.
    Zeng J; Chen Y; Tong Z; Zhou X; Zhao C; Wang K; Hughes G; Kasuga D; Bedell M; Lee C; Ferreyra H; Kozak I; Haw W; Guan J; Shaw R; Stevenson W; Weishaar PD; Nelson MH; Tang L; Zhang K
    Mol Vis; 2010 Nov; 16():2273-8. PubMed ID: 21139680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study.
    Farwick A; Dasch B; Weber BH; Pauleikhoff D; Stoll M; Hense HW
    Eye (Lond); 2009 Dec; 23(12):2238-44. PubMed ID: 19169232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).
    Hagstrom SA; Ying GS; Pauer GJT; Sturgill-Short GM; Huang J; Callanan DG; Kim IK; Klein ML; Maguire MG; Martin DF;
    Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator.
    Micklisch S; Lin Y; Jacob S; Karlstetter M; Dannhausen K; Dasari P; von der Heide M; Dahse HM; Schmölz L; Grassmann F; Alene M; Fauser S; Neumann H; Lorkowski S; Pauly D; Weber BH; Joussen AM; Langmann T; Zipfel PF; Skerka C
    J Neuroinflammation; 2017 Jan; 14(1):4. PubMed ID: 28086806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.